ARCHIVE ISSUES – DECEMBER 2022

The Journal of Precision Medicine - December 2022

Measurable Residual Disease Detection in Hematological Malignancies: A Review from Research Tool to Clinical Diagnostic

Spatialomics delivered to the clinic for improved health outcomes in Barrett’s esophagus

Implementation of Novel Precision Medicine Workflows in the Community Oncology Setting

Why Exosomes Will Power Companion Diagnostic Development in Applications for Neurodegenerative Disorders

Scaling Interpretation of Clinical Sequence Data for Rare Diseases

Cost and Complexity Can Restrict Access to Life‑Saving Precision Oncology: Data Is Giving More Cancer Patients a Voice

Assessing Measurable Residual Disease as a Genetic Biomarker for Acute Myeloid Leukemia

Validated Oncogenic Drivers: An Important Sourceto Expand Targeted Therapy Access

Data Can Fill Gaps in Antimicrobial Stewardship Left by COVID-19

Imputation and critical variants:Fast becoming essential components for predictive genomics

Moving to Real‑world Applications of Pharmacogenetic Testing

Variability in Somatic Variant Interpretation: Can Software Help?

Clinical Performance and Value Vignettes (CPVs) Decrease Clinical Care Variation, Improve Patient Outcomes, and Decrease Costs

Integrated multi-omics approach driven by artificial intelligence to realize wholecourse management of cancer

BACK TO ARCHIVE